520 related articles for article (PubMed ID: 11095247)
21. Properties of tripartite chimeras between Src and Lck.
Kashishian A; MacAuley A; Cooper JA
Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
[TBL] [Abstract][Full Text] [Related]
22. v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts.
Fincham VJ; Wyke JA; Frame MC
Oncogene; 1995 Jun; 10(11):2247-52. PubMed ID: 7784071
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
24. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
Mikkola ET; Gahmberg CG
J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
[TBL] [Abstract][Full Text] [Related]
25. v-src-induced cell shape changes in rat fibroblasts require new gene transcription and precede loss of focal adhesions.
Meijne AM; Ruuls-Van Stalle L; Feltkamp CA; McCarthy JB; Roos E
Exp Cell Res; 1997 Aug; 234(2):477-85. PubMed ID: 9260918
[TBL] [Abstract][Full Text] [Related]
26. Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.
Nakaigawa N; Weirich G; Schmidt L; Zbar B
Oncogene; 2000 Jun; 19(26):2996-3002. PubMed ID: 10871851
[TBL] [Abstract][Full Text] [Related]
27. HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells.
Oda T; Muramatsu MA; Isogai T; Masuho Y; Asano S; Yamashita T
Biochem Biophys Res Commun; 2001 Nov; 288(5):1078-86. PubMed ID: 11700021
[TBL] [Abstract][Full Text] [Related]
28. Role of c-Fes in normal and neoplastic hematopoiesis.
Yates KE; Gasson JC
Stem Cells; 1996 Jan; 14(1):117-23. PubMed ID: 8820957
[TBL] [Abstract][Full Text] [Related]
29. Truncation of c-fes via gene targeting results in embryonic lethality and hyperproliferation of hematopoietic cells.
Hackenmiller R; Simon MC
Dev Biol; 2002 May; 245(2):255-69. PubMed ID: 11977979
[TBL] [Abstract][Full Text] [Related]
30. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain.
Gouri BS; Swarup G
Indian J Biochem Biophys; 1997; 34(1-2):29-39. PubMed ID: 9343926
[TBL] [Abstract][Full Text] [Related]
31. Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues.
Rogers JA; Read RD; Li J; Peters KL; Smithgall TE
J Biol Chem; 1996 Jul; 271(29):17519-25. PubMed ID: 8663427
[TBL] [Abstract][Full Text] [Related]
32. The c-Fes family of protein-tyrosine kinases.
Smithgall TE; Rogers JA; Peters KL; Li J; Briggs SD; Lionberger JM; Cheng H; Shibata A; Scholtz B; Schreiner S; Dunham N
Crit Rev Oncog; 1998; 9(1):43-62. PubMed ID: 9754447
[TBL] [Abstract][Full Text] [Related]
33. Tyrosine phosphorylation enhances the SH2 domain-binding activity of Bcr and inhibits Bcr interaction with 14-3-3 proteins.
Peters KL; Smithgall TE
Cell Signal; 1999 Jul; 11(7):507-14. PubMed ID: 10405761
[TBL] [Abstract][Full Text] [Related]
34. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
[TBL] [Abstract][Full Text] [Related]
35. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
[TBL] [Abstract][Full Text] [Related]
37. An identity crisis for fps/fes: oncogene or tumor suppressor?
Sangrar W; Zirgnibl RA; Gao Y; Muller WJ; Jia Z; Greer PA
Cancer Res; 2005 May; 65(9):3518-22. PubMed ID: 15867340
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of Hic-5 at tyrosine 60 by CAKbeta and Fyn.
Ishino M; Aoto H; Sasaski H; Suzuki R; Sasaki T
FEBS Lett; 2000 Jun; 474(2-3):179-83. PubMed ID: 10838081
[TBL] [Abstract][Full Text] [Related]
39. Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.
Kim J; Feldman RA
Mol Cell Biol; 2002 Mar; 22(6):1903-18. PubMed ID: 11865067
[TBL] [Abstract][Full Text] [Related]
40. The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function.
Koch CA; Moran M; Sadowski I; Pawson T
Mol Cell Biol; 1989 Oct; 9(10):4131-40. PubMed ID: 2685548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
